Intravitreal bevacizumab (Avastin) for post-laser photocoagulation anterior segment ischemia in aggressive posterior retinopathy of prematurity

Sangtam, Tiakumzuk; Vinekar, Anand; Maheshwar, Bakthavatsalu; Dogra, Mangat R.; Au Eong, Kah-Guan
July 2007
Indian Journal of Ophthalmology;Jul2007, Vol. 55 Issue 4, p317
Academic Journal
No abstract available.


Related Articles

  • Prematüre Retinopatisi için Uygulanan Lazer Tedavisinin Nadir Bir Komplikasyonu: Ön Segment Iskemisi ve Koroid Dekolmanı. ŞEKEROĞLU, Mehmet Ali; HEKÎMOĞLU, Emre // Retina-Vitreus/Journal of Retina-Vitreous;Jun2014, Vol. 22 Issue 2, p153 

    Baser photocoagulation is the frequently used method for the treatment of retinopathy of prematurity. Herein, we report a premature infant with bilateral aggressive posterior retinopathy of prematurity who had unilateral anterior segment ischemia, choroidal detachment and cataract following...

  • Bevacizumab.  // Reactions Weekly;9/18/2010, Issue 1319, p11 

    The article describes the case of a male neonate who developed choroidal rupture after he received combined laser ablation treatment and intravitreal bevacizumab for aggressive posterior retinopathy of prematurity (ROP).

  • Long term refractive and structural outcome following laser treatment for zone 1 aggressive posterior retinopathy of prematurity. Shah, Parag K.; Ramakrishnan, Minu; Sadat, Bani; Bachu, Sandeep; Narendran, V.; Kalpana, N. // Oman Journal of Ophthalmology;Oct2014, Vol. 7 Issue 3, p116 

    Aim: To report the long term refractive, visual and structural outcome post-laser for zone 1 aggressive posterior retinopathy of prematurity (AP-ROP). Materials and Methods: A retrospective analysis was performed of refractive status of premature infants with zone 1 AP-ROP who underwent laser...

  • Intravitreal Bevacizumab Following Laser Therapy for Severe Retinopathy of Prematurity. Erol, Nazmiye; Gürsoy, Hüseyin; Sahin, Afsun; Basmak, Hikmet // Journal of Pediatric Ophthalmology & Strabismus;Jul/Aug2010, Vol. 47 Issue 4, pe1 

    Trial of intravitreal bevacizumab injection in 7 eyes of 4 infants with continued retinopathy of prematurity progression despite previous laser therapy was reported. Six of the eyes benefited from the therapy. Intravitreal bevacizumab injection may be an alternative therapy in progressive stage...

  • Adjunctive effect of intravitreal bevacizumab prior to lens-sparing vitrectomy in aggressive posterior retinopathy of prematurity: a case report. Sun, Hae; Choi, Kyung; Lee, Sung // Japanese Journal of Ophthalmology;Sep2012, Vol. 56 Issue 5, p476 

    Background: Intravitreal injection of bevacizumab in retinopathy of prematurity has shown satisfactory results without any systemic complications. However, increased fibrosis and tissue contraction are reported as adverse effects in some cases. Case: A premature girl, born at 29 weeks + 4 days...

  • An Evidence-Based Meta-analysis of Vascular Endothelial Growth Factor Inhibition in Pediatric Retinal Diseases: Part 1. Retinopathy of Prematurity. Mititelu, Mihai; Chaudhary, Khurram M.; Lieberman, Ronni M. // Journal of Pediatric Ophthalmology & Strabismus;Nov2012, Vol. 49 Issue 6, p332 

    Recently there has been interest in the novel, off -label use of anti-vascular endothelial growth factor (anti-VEGF) agents for various stages of retinopathy of prematurity (ROP). The authors report on the quality and depth of new evidence published from 2009 to 2011 concerning the treatment of...

  • Response to Carifi et al.'s Letter. Yang, Chang-Sue; Hung, Kuo-Che; Huang, Yi-Ming; Hsu, Wen-Ming // Journal of Ocular Pharmacology & Therapeutics;May2014, Vol. 30 Issue 4, p304 

    Chang-Sue Yang, Kuo-Che Hung,Yi-Ming Huang and Wen-Ming Hsu respond to a letter to the editor submitted in response to their article "Intravitreal Bevacizumab (Avastin) and Panretinal Photocoagulation in the Treatment of High-Risk Proliferative Diabetic Retinopathy", which appeared in a previous...

  • Intravitreal Anti-VEGF Treatment as Adjunctive Treatment in the Management of Diabetic Retinopathy. Carifi, Gianluca; Zygoura, Vasiliki; Kopsachilis, Nikolaos // Journal of Ocular Pharmacology & Therapeutics;May2014, Vol. 30 Issue 4, p303 

    A letter to the editor is presented in response to the article "Intravitreal Bevacizumab (Avastin) and Panretinal Photocoagulation in the Treatment of High-Risk Proliferative Diabetic Retinopathy" by C. S. Yang, K. C. Hung, Y. M. Huang et al., which appeared in a previous issue of the journal.

  • Choroidal ruptures after adjuvant intravitreal injection of bevacizumab for aggressive posterior retinopathy of prematurity. Atchaneeyasakul, L-O.; Trinavarat, A. // Journal of Perinatology;Jul2010, Vol. 30 Issue 7, p497 

    In recent times, laser treatment combined with intravitreal bevacizumab (Avastin) has been used rarely as early investigations to treat patients with aggressive posterior retinopathy of prematurity (ROP). We describe choroidal ruptures that were documented at 10 weeks after this combined...

  • Retinal Detachment Despite Aggressive Management of Aggressive Posterior Retinopathy of Prematurity. Suk, Kevin K.; Berrocal, Audina M.; Murray, Timothy G.; Rich, Ryan; Major, James C.; Hess, Ditte; Johnson, Rose A. // Journal of Pediatric Ophthalmology & Strabismus;Nov/Dec2010, Vol. 47 Issue 6, pe1 

    Posterior retinopathy of prematurity (ROP) is unusual in its atypical features and its aggressive, rapidly progressive course. It is more difficult to recognize and to treat, with many of these eyes progressing to retinal detachment despite multiple treatments with laser or cryotherapy. The...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics